Medicare Enrolled

Dr. Nicholas Lanciano, DO

Student in an Organized Health Care Education/Training Program · Johnstown, PA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
1450 SCALP AVE, Johnstown, PA 15904
8142695211
In practice since 2010 (16 years)
NPI: 1508184953 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lanciano from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lanciano? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lanciano

Dr. Nicholas Lanciano is a student in an organized health care education/training program specialist in Johnstown, PA, with 16 years of NPI registration. Based on federal Medicare data, Dr. Lanciano performed 408 Medicare services across 337 unique beneficiaries.

Between the years covered by Open Payments, Dr. Lanciano received a total of $214,208 from 99 pharmaceutical and/or device companies across 1701 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in student in an organized health care education/training program. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lanciano is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice ▲ Top 42% volume in PA $214,208 industry payments

Medicare Practice Summary

Medicare Utilization ↗
408
Medicare services
Top 42% in PA for student in an organized health care education/training program
337
Unique beneficiaries
$54
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~26 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
202 $63 $209
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
140 $40 $142
Awake and drowsy EEG
A test that records electrical activity in the brain while the patient is awake and drowsy.
41 $42 $688
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
25 $91 $322
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$214,208
Total received (2018-2024)
Avg $30,601/year across 7 years
Top 0% in PA for student in an organized health care education/training program
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
99
Companies
1,701
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$193,087 (90.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,230 (7.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$5,892 (2.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$9,038
2023
$20,741
2022
$26,437
2021
$58,360
2020
$38,347
2019
$36,566
2018
$24,720

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Teva Pharmaceuticals USA, Inc.
$4,668
Alexion Pharmaceuticals, Inc.
$2,469
Abbott Laboratories
$344
ABBVIE INC.
$325
EMD Serono, Inc.
$160
UCB, Inc.
$112
Eisai Inc.
$105
SK Life Science, Inc.
$81
Neurocrine Biosciences, Inc.
$74
PFIZER INC.
$65
Lilly USA, LLC
$65
ARGENX US, INC.
$62
Vanda Pharmaceuticals Inc.
$56
Lundbeck LLC
$52
TG Therapeutics, Inc.
$42
Otsuka America Pharmaceutical, Inc.
$38
MDD US Operations, LLC
$34
Neurelis, Inc.
$33
MITSUBISHI TANABE PHARMA AMERICA, INC.
$31
JAZZ PHARMACEUTICALS INC.
$28
Amneal Pharmaceuticals LLC
$28
Genentech USA, Inc.
$25
Takeda Pharmaceuticals U.S.A., Inc.
$23
Novo Nordisk Inc
$22
Biogen, Inc.
$21
CSL Behring
$18
Kyowa Kirin, Inc.
$16
LivaNova USA, Inc.
$15
Virtus Pharmaceuticals LLC
$15
Cycle Pharmaceuticals Inc
$12
Top 3 companies account for 82.8% of 2024 payments
All-time payments by company (2018-2024) ›
GENZYME CORPORATION
$45,803
Alexion Pharmaceuticals, Inc.
$36,551
Teva Pharmaceuticals USA, Inc.
$28,695
EMD Serono, Inc.
$28,478
Allergan, Inc.
$16,495
ABBVIE INC.
$15,296
AbbVie Inc.
$12,426
Genentech USA, Inc.
$9,261
Biogen, Inc.
$6,165
LivaNova USA, Inc.
$3,317
Abbott Laboratories
$1,623
UCB, Inc.
$790
Amgen Inc.
$561
Sunovion Pharmaceuticals Inc.
$524
Amneal Pharmaceuticals LLC
$499
Novartis Pharmaceuticals Corporation
$416
Lundbeck LLC
$371
Neurocrine Biosciences, Inc.
$326
Biohaven Pharmaceutical Holding Company Ltd.
$312
PFIZER INC.
$304
ARGENX US, INC.
$303
Adamas Pharmaceuticals, Inc.
$294
SK Life Science, Inc.
$262
Kyowa Kirin, Inc.
$235
Scilex Pharmaceuticals Inc.
$228
Janssen Pharmaceuticals, Inc
$213
Eisai Inc.
$184
ACADIA Pharmaceuticals Inc
$183
Supernus Pharmaceuticals, Inc.
$178
JAZZ PHARMACEUTICALS INC.
$159
Biohaven Pharmaceuticals, Inc.
$159
Grifols USA, LLC
$159
Acorda Therapeutics, Inc
$158
Allergan Inc.
$154
Otsuka America Pharmaceutical, Inc.
$153
Greenwich Biosciences, Inc.
$143
Lilly USA, LLC
$142
Upsher-Smith Laboratories LLC
$131
E.R. Squibb & Sons, L.L.C.
$122
Neurelis, Inc.
$117
MDD US Operations, LLC
$113
Celgene Corporation
$111
MITSUBISHI TANABE PHARMA AMERICA, INC.
$103
CSL Behring
$97
BioDelivery Sciences International, Inc.
$96
Impax Laboratories, Inc.
$79
Ipsen Biopharmaceuticals, Inc
$77
EISAI INC.
$73
Mallinckrodt LLC
$69
Harmony Biosciences LLC
$67
Xeris Pharmaceuticals, Inc.
$60
Vanda Pharmaceuticals Inc.
$56
Bioventus LLC
$55
US WorldMeds, LLC
$52
Strongbridge US INC.
$51
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$51
Sentynl Therapeutics, Inc.
$49
Mitsubishi Tanabe Pharma America, Inc.
$49
W. L. Gore & Associates, Inc.
$46
BANNER LIFE SCIENCES, LLC
$45
Bayer HealthCare Pharmaceuticals Inc.
$45
Avanir Pharmaceuticals, Inc.
$45
Horizon Therapeutics plc
$43
TG Therapeutics, Inc.
$42
Novo Nordisk Inc
$42
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$41
Daiichi Sankyo Inc.
$40
Boston Scientific Corporation
$39
Banner Life Sciences, LLC
$38
SI-BONE, Inc.
$38
Philips Electronics North America Corporation
$33
Avion Pharmaceuticals
$29
AstraZeneca Pharmaceuticals LP
$28
ARBOR PHARMACEUTICALS, INC.
$28
Takeda Pharmaceuticals U.S.A., Inc.
$23
Akcea Therapeutics, Inc.
$20
Alnylam Pharmaceuticals Inc.
$20
Advanced Respiratory, Inc
$19
PORTOLA PHARMACEUTICALS, INC.
$19
Collegium Pharmaceutical, Inc.
$19
UPSHER-SMITH LABORATORIES LLC
$18
Amylyx Pharmaceuticals, Inc.
$17
PORTOLA PHARMACEUTICALS, LLC
$16
Nevro Corp.
$16
Electronic Waveform Lab, Inc.
$16
Bausch Health US, LLC
$15
Virtus Pharmaceuticals LLC
$15
GE HEALTHCARE
$15
HARMONY BIOSCIENCES LLC
$14
GE HealthCare
$14
Jazz Pharmaceuticals Inc.
$14
Arbor Pharmaceuticals, Inc.
$14
RedHill Biopharma Inc.
$14
Medtronic, Inc.
$13
Cycle Pharmaceuticals Inc
$12
Kaleo, Inc.
$12
Medtronic USA, Inc.
$11
Merck Sharp & Dohme Corporation
$11
Ceribell, Inc.
$6
Top 3 companies account for 51.8% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · ANDEXXA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Aimovig · Austedo XR · BAFIERTAM · BELBUCA · BELSOMRA · BOTOX · BOTOX THERAPEUTIC · BRILINTA · BRIUMVI · BUNAVAIL 2.1 mg 30-count box · Betaseron · Briviact · COMIRNATY · Ceribell Rapid Response EEG · DUOPA · DYSPORT · Dhivy · Durolane · Dysport · EMGALITY · EPIDIOLEX · ETERNA · Epidiolex · Evzio · Fintepla · Fycompa · GILENYA · GOCOVRI · GORE CARDIOFORM Septal Occluder · GVOKE PFS · Gamunex-C · General - DBS · Gocovri · HYQVIA · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · INTELLIS · INTERSTIM · Infinity DBS Pulse Generators · KESIMPTA · KEVEYIS · KISUNLA · KYNMOBI · LEMTRADA · LEVORPHANOL TARTRATE · LYRICA · Leqembi · Levorphanol · Levorphanol Tartrate · Lucemyra/Lofexidine · MAYZENT · MIGRANAL · Mavenclad · Morphabond ER · Movantik · NAMZARIC · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Nourianz · Nuedexta · Nymalize · OCREVUS · OCTRODE · ONFI · ONGENTYS · ONPATTRO · OXTELLAR XR · Ocrevus · Ocrevus Zunovo · Octrode SCS Leads · Omnia · Ongentys · Ormalvi · PANZYGA · PAXLOVID · PONVORY · PROCLAIM · Ponvory · Proclaim IPG · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RADICAVA · RELISTOR · RELYVRIO · REXULTI · RYTARY · Radicava · Rebif · Rystiggo · SKYCLARYS · SOLIRIS · SPINRAZA · SUNOSI · Soliris · Stimrouter Implantable Kit · TECFIDERA · TEGSEDI · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · The Vest System Model 105 Home Care · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAKIX · WATCHMAN Access System · Wakix · Wellcentive Undiv · XTAMPZA · XYREM · XYWAV · Xadago · ZEPOSIA · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zilbrysq · iFuse Implant · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (90%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in student in an organized health care education/training program and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for student in an organized health care education/training program in PA.

Looking for a student in an organized health care education/training program specialist in Johnstown?
Compare student in an organized health care education/training programs in the Johnstown area by procedure volume, costs, and industry payment transparency.
Browse student in an organized health care education/training programs nearby

Geographic Context

Student in an organized health care education/training programs within 10 mi
37
Per 100K population
28.0
County median income
$56,292
Nearest hospital
CONEMAUGH MEMORIAL MEDICAL CENTER
7.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Lanciano is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 0% of PA peers, with 16 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Lanciano experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Lanciano performed 202 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lanciano receive payments from pharmaceutical companies?
Yes. Dr. Lanciano received a total of $214,208 from 99 companies across 1,701 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lanciano's costs compare to other student in an organized health care education/training programs in Johnstown?
Dr. Lanciano's average Medicare payment per service is $54. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lanciano) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →